Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (341-350 of 409) with videos related to

Pageof 41
Sort By:
Nature Genetics|June 4, 2013
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancerJian Yu, Susan Kane, Jiong Wu, et al.
Nature Biotechnology|December 23, 2008
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyJinyan Du, Paula Bernasconi, Karl R Clauser, et al.
Journal of the National Cancer Institute|November 29, 2015
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate CancerThomas U Ahearn, Andreas Pettersson, Ericka M Ebot, et al.
Nature Communications|February 28, 2015
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneityBiswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Multi-omics integration and batch correction using a modality-agnostic deep learning frameworkJose Ignacio Alvira Larizgoitia, Gabriele Partel, Lorenzo Venturelli, et al.
Plos Genetics|November 19, 2010
Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesisMark M Pomerantz, Yashaswi Shrestha, Richard J Flavin, et al.
Cancer Medicine|May 22, 2014
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladderElizabeth A Guancial, Lillian Werner, Joaquim Bellmunt, et al.
Cancer Immunology Research|October 1, 2015
MicroRNA MIR21 and T Cells in Colorectal CancerKosuke Mima, Reiko Nishihara, Jonathan A Nowak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
SPINK1 protein expression and prostate cancer progressionRichard Flavin, Andreas Pettersson, Whitney K Hendrickson, et al.
Pageof 41

Showing results (341-350 of 409) with videos related to

Sort By:
Pageof 41
Nature Genetics|June 4, 2013
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerAndrea Lunardi, Ugo Ala, Mirjam T Epping, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancerJian Yu, Susan Kane, Jiong Wu, et al.
Nature Biotechnology|December 23, 2008
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyJinyan Du, Paula Bernasconi, Karl R Clauser, et al.
Journal of the National Cancer Institute|November 29, 2015
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate CancerThomas U Ahearn, Andreas Pettersson, Ericka M Ebot, et al.
Nature Communications|February 28, 2015
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneityBiswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Multi-omics integration and batch correction using a modality-agnostic deep learning frameworkJose Ignacio Alvira Larizgoitia, Gabriele Partel, Lorenzo Venturelli, et al.
Plos Genetics|November 19, 2010
Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesisMark M Pomerantz, Yashaswi Shrestha, Richard J Flavin, et al.
Cancer Medicine|May 22, 2014
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladderElizabeth A Guancial, Lillian Werner, Joaquim Bellmunt, et al.
Cancer Immunology Research|October 1, 2015
MicroRNA MIR21 and T Cells in Colorectal CancerKosuke Mima, Reiko Nishihara, Jonathan A Nowak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
SPINK1 protein expression and prostate cancer progressionRichard Flavin, Andreas Pettersson, Whitney K Hendrickson, et al.
Pageof 41